Le Lézard
Classified in: Health
Subjects: PDT, MAT

Prima Launches Chill Out, the First of its Kind Functional Chew for Stress


New Patent-Pending Gummy Alternative is Vegan and Free of Refined Sugar and Artificial Dyes

LOS ANGELES, April 20, 2022 /PRNewswire/ -- The Uplifters' Prima, PBC ("Prima") the award-winning, science-backed whole body wellness brand making potent plant therapeutic skincare, body care and supplements announced its newest product launch, Chill Out, a highly innovative vegan CBD chew with a patent-pending, nutrient-dense formula that outperforms the traditional "gummy" and "CBD gummy" in ingredient quality, delivery system and overall efficacy.

Co-developed with a neuropharmacologist and nutritional biochemist, Chill Out is designed to address underlying nutrient deficiencies of the body that contribute to stress, burn-out, and fatigue. Its patent-pending, plant-powered delivery system addresses major deficiencies with traditional gummies. Combining 20mg broad-spectrum organic hemp CBD per serving plus magnesium and ten neuro-supportive nutrients, Chill Out reduces stress, soothes tension and supports healthy adrenal function.

"The modern day stress epidemic is wreaking havoc on our bodies and minds, and we all need daily, fast relief to escape the chaos. Unlike the standard gummies that are loaded with sugar and toxins, we spent over two years designing a truly health-conscious formula that enables immediate uptake via oral micro-vascular absorption, surpassing traditional gummies with its exceptional bioavailability and optimal absorption. Co-developed by leading doctors, Chill Out's patent-pending plant-based formula manages healthy cortisol levels and actively calms the body and mind within minutes. It's a delightful, instant way to take the edge off and just chill, without the hangover or the high," said Christopher Gavigan, Prima's Founder and Co-CEO.

The $3.7B global gummy vitamin and supplement market is ripe for innovation and a healthier, better-for-you solution. The majority of products on the market contain known questionable, unhealthy ingredient types: refined, immune-suppressing sugars, toxic and even carcinogenic FD&C food dyes, and animal by-products like gelatin. As the $14.2B vegan market size reaches $31.4B by 2026, informed consumers are demanding alternatives that align with their values as they adopt more plant-led lifestyles. The $21B global CBD gummy market is expected to grow to $13.9B by 2028, and Prima's Chill Out will set the new elevated standard for pure, conscious ingredients and format innovation.

"Due to the nature of the gummy product format and manufacturing process, the serving size is typically four to five gummies to ensure high doses of meaningful ingredients, which leads to excessive sugar and calories for a nutritional benefit, or alternatively, a very limited ingredient offering. Chill Out's novel food matrix allows for dense nutrient and vitamin delivery in only two refined-sugar-free chews," said Laurel Angelica Myers, Prima's Co-Founder and Co-CEO.  

Chill Out's launch campaign, "No Gummy Business," aims to educate consumers about the negative health effects of traditional CBD gummies and gummy vitamins by questioning the typical ingredients in these products.

"The CBD gummy is contradictory in nature. How can we be calling this a health product when the majority on the market contain known toxins like refined sugar, artificial food dyes, and animal byproducts like gelatin that don't align with the vegan and plant-based lifestyle? It's time we stop undermining the helpful active ingredients in these products with unnecessary additives. Finally, there's a better alternative, with added benefits," said Jessica Assaf, Prima's Co-Founder and Chief Education Officer. 

Prima is available online at prima.co and at over 1000 retailers nationwide, including Sephora, The Vitamin Shoppe, Thrive Market, The Detox Market, Amazon, Nordstrom, Pharmaca, Erewhon Market, and Milk & Honey. Chill Out is available on Prima's DTC website and app, and it will be launching in 600+ The Vitamin Shoppe stores nationwide in July.

About Prima
Prima is a science-backed whole body wellness brand that makes potent plant therapeutic skincare, body care and supplements with organic hemp CBD and functional botanicals to help combat stress and target issues at their source. Prima's products are made with the highest standards of purity, potency and transparency, using clinically studied plant ingredients. Built on a core foundation of sustainability, transparency, accountability, and corporate responsibility, Prima is Climate Neutral Certified, certified Plastic Neutral, and a certified B Corps. Prima is a privately held Public Benefit Corporation (PBC) based in Santa Monica, CA. www.prima.co

About Chill Out
Chill Out features 20mg of Prima's bioavailable and organic hemp CBD per serving, with a magnesium and neuro nutrient blend and a patent-pending delivery system and formula composition:

Organic Hemp CBD Extract
Meticulously extracted broad-spectrum hemp rich in naturally occurring CBD, terpenes and polyphenols to support balance and overall wellbeing.

Magnesium + Neuro Nutrient Blend
100mg highly bioavailable Magnesium enhanced with Ascorbyl Palmitate, Vitamin C, Niacin, Citrus Bioflavonoids, Pantothenic Acid, Pyridoxine, Riboflavin, Thiamin, PABA, Chromium, and Biotin.

Patent-Pending Delivery System and Formula Composition 
Mucoadhesive, saccharide-based, patent-pending, soft chew delivery system with formula composition designed for bioavailability and maximum benefit impact.

Media Contact:
Jessica Assaf
[email protected]

SOURCE Prima


These press releases may also interest you

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...

at 11:55
The "Infectious Vaccine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Infectious Vaccine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...



News published on and distributed by: